Promising pre-clinical results for USask VIDO-InterVac COVID-19 vaccine
A COVID-19 vaccine candidate developed by the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has cleared another major milestone in moving towards human clinical trials.…
